Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Steroid hormones and their metabolites within the central nervous system are commonly defined as neuroactive steroids or neurosteroids.
Although neuroactive steroids have been shown to improve learning and memory ability and protect against amyloid beta (Aβ) peptide-induced neurotoxicity, changes in their level during Alzheimer's disease and their role in Aβ-mediated cognitive impairment remain elusive given the limitation in sample sizes and analysis methods.
To gain a better understanding on the role of neuroactive steroids in the pathology of Alzheimer's disease, Dr. Sha Liu and colleagues from Hebei Medical University, China investigated the effect of progesterone administration against Aβ25-35-induced impairment in vivo.
In their study, intracerebral injection of aggregated Aβ25-35 into the bilateral hippocampal CA1 region impaired learning and memory abilities of rats, accompanied by reduced levels of progesterone.
Treatment of these Alzheimer's disease rats with exogenous progesterone could reverse cognitive impairment.
Therefore, this study, published in Neural Regeneration Research (Vol. 8, No. 30, 2013), provides a possible therapeutic strategy for Alzheimer's disease via neuroactive steroids, particularly progesterone.
Article: " Metabolic alteration of neuroactive steroids and protective effect of progesterone in Alzheimer's disease-like rats," by Sha Liu1, Honghai Wu2, Gai Xue2, Xin Ma1, Jie Wu1, Yabin Qin1, Yanning Hou1, 2 (1 Hebei Medical University, Shijiazhuang 050017, Hebei Province, China; 2 Department of Pharmacy, Bethune International Peace Hospital of Chinese PLA, Shijiazhuang 050082, Hebei Province, China)
Liu S, Wu HH, Xue G, Ma X, Wu J, Qin YB, Hou YN. Metabolic alteration of neuroactive steroids and protective effect of progesterone in Alzheimer's disease-like rats. Neural Regen Res. 2013;8(30):2800-2810. doi:10.3969/j.issn.1673-5374.2013.30.002
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Alzheimer's / Dementia category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Research, Neural Regeneration. "Some cognitive impairment of Alzheimer's disease may be due progesterone changes." Medical News Today. MediLexicon, Intl., 10 Dec. 2013. Web.
16 Apr. 2014. <http://www.medicalnewstoday.com/releases/269865>
Research, N. (2013, December 10). "Some cognitive impairment of Alzheimer's disease may be due progesterone changes." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/269865.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.